[Therapy of diabetic nephropathy. Effects of ACE inhibition on microcirculation].
The development of diabetic microangiopathies is of decisive importance for the long-term prognosis of diabetes mellitus. For example, diabetic nephropathy is one of the the most common causes of terminal kidney failure. Primary prevention of diabetic nephropathy is best achieved by establishing good metabolic control. To ensure early pharmacological intervention of incipient diabetic nephropathy, screening for microalbuminuria is recommended at least once a year. A major element in the pathogenesis of diabetic nephropathy is a disordered microcirculation characterized by abnormal hemodynamics with elevated capillary pressure and microvascular resistance. Angiotensin converting enzyme inhibitors (ACE inhibitors) effectively act on these pathophysiological events by dilation of the vasa efferentia of the glomeruli. By means of videocapillaroscopy and laser doppler imaging also distinct changes in microcirculation can be detected. Investigations with these methods provided evidence that ACE inhibitors might also be useful in the primary prevention of diabetic nephropathy. Therefore, ACE inhibitors are useful pharmaceutical agents in the treatment of diabetic nephropathy.
Haak
T
T
Medizinische Klinik I, Schwerpunkt Endokrinologie, Diabetologie und Stoffwechsel, Universität Frankfurt/Main.
Haak
E
E
Jungmann
E
E
Kusterer
K
K
Usadel
K H
KH
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001783:Blood Flow Velocity / Q000187:drug effects; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D006801:Humans; D007668:Kidney / Q000098:blood supply*; D008833:Microcirculation / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors
Therapie der diabetischen Nephropathie. Effekte der ACE-Hemmung auf die Mikrozirkulation.